ARIAD Pharma (ARIA) Receives Document Request from Sanders, Cummings

October 20, 2016 1:01 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.


ARIAD Pharma (NASDAQ: ARIA) shares were pressured Thursday after Representative Eliijah Cummings and Senator Bernard Sanders sent a letter to the company's CEO requesting information related to price increases on Iclusig, its treatment for chronic myeloid leukemia.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Litigation, Trader Talk

Related Entities

Raising Prices

Add Your Comment